---
schema_version: "secwatch.filing_event.v1"
accession: "0000105770-22-000010"
form_type: "8-K"
ticker: "WST"
cik: "0000105770"
company_name: "WEST PHARMACEUTICAL SERVICES INC"
filed_at: "2022-04-01T23:59:59+00:00"
generated_at: "2026-06-26T10:12:03.724760+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# West Pharma amends credit facility to $500M, extends to 2027; adds Japanese subsidiary as borrower

## Summary
- Increased credit facility from $300M to $500M senior unsecured revolving; maturity extended to March 31, 2027.
- Added West Pharmaceutical Services Holding Japan Godo Kaisha as additional borrower under the facility.
- Interest: Term SOFR + 0.10% + margin of 87.5-137.5 bps or base rate + 0-37.5 bps.
- Financial covenant: Net Consolidated Debt to modified EBITDA ratio max 3.5:1 (4.0:1 for qualified acquisitions up to 4 quarters).

## SEC filing metadata
- accession: 0000105770-22-000010
- form_type: 8-K
- ticker: WST
- cik: 0000105770
- company_name: WEST PHARMACEUTICAL SERVICES INC
- filed_at: 2022-04-01T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/105770/000010577022000010/0000105770-22-000010-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/105770/000010577022000010/wst-20220331.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000105770-22-000010
- JSON: https://secwatch.observer/filing/0000105770-22-000010.json
- Plain text: https://secwatch.observer/filing/0000105770-22-000010.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.